2'-Deoxyadenosine 5'-diphosphoribose is an endogenous TRPM2 superagonist

  • Ralf Fliegert
  • Andreas Bauche
  • Adriana-Michelle Wolf Pérez
  • Joanna M Watt
  • Monika D Rozewitz
  • Riekje Winzer
  • Mareike Janus
  • Feng Gu
  • Annette Rosche
  • Angelika Harneit
  • Marianne Flato
  • Christelle Moreau
  • Tanja Kirchberger
  • Valerie Wolters
  • Barry V L Potter
  • Andreas H Guse

Abstract

Transient receptor potential melastatin 2 (TRPM2) is a ligand-gated Ca(2+)-permeable nonselective cation channel. Whereas physiological stimuli, such as chemotactic agents, evoke controlled Ca(2+) signals via TRPM2, pathophysiological stimuli such as reactive oxygen species and genotoxic stress result in prolonged TRPM2-mediated Ca(2+) entry and, consequently, apoptosis. To date, adenosine 5'-diphosphoribose (ADPR) has been assumed to be the main agonist for TRPM2. Here we show that 2'-deoxy-ADPR was a significantly better TRPM2 agonist, inducing 10.4-fold higher whole-cell currents at saturation. Mechanistically, this increased activity was caused by a decreased rate of inactivation and higher average open probability. Using high-performance liquid chromatography (HPLC) and mass spectrometry, we detected endogenous 2'-deoxy-ADPR in Jurkat T lymphocytes. Consistently, cytosolic nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) and nicotinamide adenine dinucleotide (NAD)-glycohydrolase CD38 sequentially catalyzed the synthesis of 2'-deoxy-ADPR from nicotinamide mononucleotide (NMN) and 2'-deoxy-ATP in vitro. Thus, 2'-deoxy-ADPR is an endogenous TRPM2 superagonist that may act as a cell signaling molecule.

Bibliografische Daten

OriginalspracheEnglisch
ISSN1552-4450
DOIs
StatusVeröffentlicht - 09.2017
PubMed 28671679